Physical inactivity has consistently been shown to be one of the most powerful, modifiable risk factors for all causes of death and disease, alongside smoking and obesity.
This interactive body map brings together scientific evidence on the links between lack of physical activity and disease.
Click on the coloured dots on the body, or choose a specific disease from the dropdown menu, or cycle through all diseases via the next and previous buttons.
To use the map, click on any of the coloured dots on the body, or choose a specific disease from the dropdown menu. You can also filter by disease or condition type.
This is the first in our package on the benefits of exercise. Read other articles in the package here.
For a copy of the data and notes on the methodology used for the calculations, please visit The Conversation’s GitHub page.
Carol Maher receives funding from the National Health and Medical Research Council and the National Heart Foundation.
Tim Olds receives funding from the ARC and the NHMRC.
This article was originally published on The Conversation. Read the original article.


RFK Jr. Overhauls Federal Autism Panel, Sparking Medical Community Backlash
U.S. Officials Express Optimism Over New CDC Director Selection Amid Vaccine Policy Turmoil
Moderna to Pay Up to $2.25B to Settle LNP Patent Dispute Over COVID-19 Vaccine Technology
FDA Fast-Track Drug Reviews Delayed Over Safety and Efficacy Concerns
Sanofi Reports Positive Late-Stage Results for Amlitelimab in Eczema Treatment
Novo Nordisk Shares Tumble After CagriSema Misses Key Trial Endpoint
FDA Warns Novo Nordisk Over Misleading Ozempic Ad Claims
Novartis’ Vanrafia Shows Strong Phase 3 Results in IgA Nephropathy, Paving Way for Full Approval
Innovent Biologics Shares Rally on New Eli Lilly Oncology and Immunology Deal
Merck Raises Growth Outlook, Targets $70 Billion Revenue From New Drugs by Mid-2030s
Viking Therapeutics Sees Growing Strategic Interest in $150 Billion Weight-Loss Drug Market 



